| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e059ec4b433ddfaa926f6cfe56998497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69adb72a6f8ba39e7d3c08d66ab93022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b0896779394aad63773239249b4d6c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d189b10028d1697dc0392efe2902921 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6429
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21005 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-10 |
| filingDate |
1996-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c259c23d39a29382ca9215ff7e11793
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f39b810dc953a29c24172f9b6768693
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_774b55298592e44aa8a26193b527cf78 |
| publicationDate |
1996-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9631245-A1 |
| titleOfInvention |
Autologous fibrin glue and methods for its preparation and use |
| abstract |
A fibrin glue includes a fibrinogen component and a thrombin component, both prepared from single donor plasma. The plasma is precipitated to produce a precipitate containing fibrinogen and a supernatant containing the thrombin. The precipitate may be resuspended in a small volume of supernatant and used as the fibrinogen component. The supernatant is further treated by clotting to convert residual fibrinogen to fibrin and filtration to remove the fibrin. Optionally, at least a portion of the anti-thrombin III originally present in the supernatant may be removed to prolong thrombin activity therein. The resulting serum can be used as the thrombin component. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9811925-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1104323-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1104323-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6472162-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9096839-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6096309-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003517272-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6280727-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7838039-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7056722-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8303993-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4666764-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0074713-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7811607-B2 |
| priorityDate |
1995-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |